Biology of Krüppel-like factor 6 transcriptional regulator in cell life and death.

An essential role for the Krüppel-like transcription factor family has been determined in the regulation of remarkable processes including cell proliferation, differentiation, signal transduction, oncogenesis, and cell death. A member of this group, Krüppel-like factor 6 (KLF6), identified on the basis of its ability to regulate a group of genes belonging to the carcinoembryonic antigen gene family, has been involved in human carcinogenesis. Early studies proposed a tumor suppressor function for KLF6 because of its ability to reduce cell proliferation through several biochemical mechanisms including regulation of cell cycle components, oncogene products, and apoptosis. Mutations within the klf6 gene, decreased expression and/or loss-of-heterozygosity were associated with the development of different human malignancies, and, hence, further supporting the tumor suppressor function of KLF6. This view has been challenged by other studies in distinct types of human cancers describing infrequent genetic alterations of klf6 gene or even enhanced expression in some tumors. The scenario about KLF6 function became still more complex as the description of oncogenic KLF6 splice variant 1 (SV1) with dominant negative activity against the wild type KLF6 (wtKLF6) protein. Additionally, increased evidence is suggesting that KLF6 is a bonafide target of several signaling cascades, which ultimate regulatory effect on this protein could drive decisions of cell life and death, facing the dilemma about how wtKLF6 could be involved in both processes. These apparently conflicting situations, emerged by apparently opposite effects mediated by wtKLF6, may be related, at least in part, to the biological cross-talk with the c-Jun oncoprotein. Depending on the stimulus received by the cell, wtKLF6 interaction with c-Jun determines different cell outcomes such as proliferation control or apoptosis. Thus, KLF6 responsiveness represents a kind of cell warning signal on receiving different stimuli, including oncogenic activation and microbial infections, orchestrating the implementation of proliferation and apoptotic programs.

Andreoli V ，Gehrau RC ，Bocco JL 《-》

The role of KLF6 and its splice variants in cancer therapy.

DiFeo A ，Martignetti JA ，Narla G 《-》

In vivo regulation of p21 by the Kruppel-like factor 6 tumor-suppressor gene in mouse liver and human hepatocellular carcinoma.

Narla G ，Kremer-Tal S ，Matsumoto N ，Zhao X ，Yao S ，Kelley K ，Tarocchi M ，Friedman SL ... -  《ONCOGENE》

Targeted inhibition of the KLF6 splice variant, KLF6 SV1, suppresses prostate cancer cell growth and spread.

Narla G ，DiFeo A ，Yao S ，Banno A ，Hod E ，Reeves HL ，Qiao RF ，Camacho-Vanegas O ，Levine A ，Kirschenbaum A ，Chan AM ，Friedman SL ，Martignetti JA ... -  《CANCER RESEARCH》

Krüppel-like factor 6 is frequently down-regulated and induces apoptosis in non-small cell lung cancer cells.

Ito G ，Uchiyama M ，Kondo M ，Mori S ，Usami N ，Maeda O ，Kawabe T ，Hasegawa Y ，Shimokata K ，Sekido Y ... -  《CANCER RESEARCH》